Leupin Nicolas
Former Chief Medical Officer
Leupin Nicolas has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Leupin Nicolas is listed as Former Chief Medical Officer at NovoCure Ltd. Inside the rolling window, Leupin Nicolas reported no open-market purchases and 2 open-market sales totaling $29K in NVCR. The largest disclosed transaction in the window is a sale of 1,100 NVCR shares on Mar 4, 2026, worth $15K.
Companies traded
Other insiders at NVCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$29K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Leupin Nicolas made?
Leupin Nicolas has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Leupin Nicolas trade?
Leupin Nicolas has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was Leupin Nicolas's most recent SEC Form 4 filing?
Leupin Nicolas's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Leupin Nicolas's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Leupin Nicolas is listed as Former Chief Medical Officer.
What is Leupin Nicolas's total buy and sell value in the current window?
Inside the rolling retention window, Leupin Nicolas bought $0 and sold $29K based on SEC Form 4 filings.
What was Leupin Nicolas's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,100 NVCR shares on 2026-03-04, worth $15K, per SEC Form 4 filings.